ITD Cementation India Limited (BOM:509496)

Marinus Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	92,578	90,969	77,179	50,909	38,090	27,277
Revenue	92,578	90,969	77,179	50,909	38,090	27,277
Revenue Growth (YoY)	11.99%	17.87%	51.60%	33.65%	39.64%	-4.65%
Cost of Revenue	59,669	59,201	50,280	32,513	24,204	16,572
Gross Profit	32,909	31,768	26,899	18,396	13,886	10,706
Selling, General & Admin	13,287	13,058	10,829	8,062	6,348	5,303
Other Operating Expenses	10,783	9,985	8,619	6,331	4,564	3,268
Operating Expenses	25,904	24,962	21,527	15,529	11,937	9,572
Operating Income	7,005	6,807	5,372	2,867	1,949	1,133
Interest Expense	-1,470	-1,500	-1,477	-1,077	-979.07	-970.59
Interest & Investment Income	303.82	303.82	331.25	169.21	50.42	84.7
Earnings From Equity Investments	62.57	-7.58	158.25	342.64	329.89	330.38
Currency Exchange Gain (Loss)	-39.74	-39.74	26.11	-3.08	-44.05	-5.92
Other Non Operating Income (Expenses)	-698.21	-684.13	-647.42	-527.86	-434.5	-407.1
EBT Excluding Unusual Items	5,164	4,879	3,763	1,770	871.88	164.67
Gain (Loss) on Sale of Assets	147.75	147.75	59.29	8.93	29.55	34.57
Other Unusual Items	-	-	-	59.41	-	-
Pretax Income	5,313	5,028	3,830	1,839	937.62	200.04
Income Tax Expense	1,209	1,295	1,089	591.48	244.21	40.52
Earnings From Continuing Operations	4,104	3,733	2,742	1,247	693.41	159.52
Minority Interest in Earnings	-5.28	-5.29	-4.51	-4.83	-5.36	-1.96
Net Income	4,098	3,728	2,737	1,242	688.05	157.56
Net Income to Common	4,098	3,728	2,737	1,242	688.05	157.56
Net Income Growth	27.39%	36.19%	120.32%	80.57%	336.69%	-63.50%
Shares Outstanding (Basic)	172	172	172	172	172	172
Shares Outstanding (Diluted)	172	172	172	172	172	172
Shares Change (YoY)	-0.03%	-	-	-	-	-
EPS (Basic)	23.86	21.70	15.93	7.23	4.01	0.92
EPS (Diluted)	23.86	21.70	15.93	7.23	4.01	0.92
EPS Growth	27.46%	36.22%	120.33%	80.51%	336.69%	-63.50%
Free Cash Flow	-	-251.56	3,479	527.6	2,277	458.83
Free Cash Flow Per Share	-	-1.46	20.25	3.07	13.25	2.67
Dividend Per Share	-	2.000	1.700	0.750	0.450	0.120
Dividend Growth	-	17.65%	126.67%	66.67%	275.00%	-60.00%
Gross Margin	35.55%	34.92%	34.85%	36.13%	36.46%	39.25%
Operating Margin	7.57%	7.48%	6.96%	5.63%	5.12%	4.15%
Profit Margin	4.43%	4.10%	3.55%	2.44%	1.81%	0.58%
Free Cash Flow Margin	-	-0.28%	4.51%	1.04%	5.98%	1.68%
EBITDA	8,788	8,608	7,248	3,815	2,761	1,825
EBITDA Margin	9.49%	9.46%	9.39%	7.49%	7.25%	6.69%
D&A For EBITDA	1,783	1,802	1,876	948.13	812.13	691.43
EBIT	7,005	6,807	5,372	2,867	1,949	1,133
EBIT Margin	7.57%	7.48%	6.96%	5.63%	5.12%	4.15%
Effective Tax Rate	22.76%	25.75%	28.42%	32.17%	26.05%	20.25%
Revenue as Reported	93,120	91,526	77,659	51,195	38,209	27,402

Source: S&P Global Market Intelligence. Standard template. Financial Sources.